CareDx Announces Repurchase of 5% of Outstanding Shares
Board of Directors Authorizes New $50 Million Share Repurchase Program
BRISBANE, Calif., June 03, 2025--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that it has completed the repurchase of $50 million of its common stock representing approximately 5% of outstanding shares.
The share repurchase follows the completion of the company's seventh consecutive quarter of testing services volume growth and a first-quarter total revenue of $84.7 million, representing 18% year-over-year growth. CareDx ended the first quarter with $231 million in cash, cash equivalents, marketable securities, and no debt.
"The investments we have made in our commercial organization and operational infrastructure are translating into growth. We saw a clear opportunity to return value to our shareholders at our current price without disrupting the ongoing development of our innovation pipeline," said John W. Hanna, President and CEO of CareDx. "I continue to have confidence in our ability to drive profitable growth and achieve our long term plan of $500 million in revenue and 20% adjusted EBITA in 2027."
Following the completion of the program, the Company's Board of Directors authorized a new share repurchase program of up to $50 million of the Company's outstanding common stock over the next 24 months. Repurchases under the new program may be made at the Company's discretion in open market purchases, privately negotiated transactions, or through other means, in accordance with applicable laws and regulations. The timing and actual number of shares repurchased will depend on a variety of factors, including price, market conditions, and other considerations.
About CareDx – The Transplant Company
CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit www.caredx.com.
Forward Looking Statements
This press release includes forward-looking statements related to CareDx, Inc., including statements regarding the anticipated repurchase of the Company's common stock and its expected impact. These forward-looking statements are based upon information that is currently available to CareDx and its current expectations, speak only as of the date hereof, and are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including general economic and market factors; and other risks discussed in CareDx's filings with the SEC. Please refer to CareDx's filings with the SEC for a full discussion of potential risks.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250603847560/en/
Contacts
Investor RelationsCaroline Cornerinvestor@caredx.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Factbox-UK Market Exodus: Companies that have moved away from a London listing
(Reuters) -British money transfer firm Wise became the latest UK listed firm on Thursday to say that it intends to move its primary listing to the U.S. from London. A growing number of companies have shelved or shifted plans to list in London, due to investor pushback and Brexit-related challenges that have pressured UK market valuations. Instead, they have opted for the U.S. and other markets, where they see stronger appetite and higher valuations. Cobalt: The Glencore-backed metals investor scrapped its plans for a London IPO on Wednesday, which, according to one source, was driven by a lack of demand. The company, valued at around $230 million, would have seen London's largest market debut since Air Astana's listing in February 2024. Indivior: The drugmaker said on Monday it will cancel its secondary listing on the London Stock Exchange effective July 25, citing cost savings and a desire to align more closely with its U.S.-focused operations. The 1.25 billion pound ($1.70 billion) pharmaceutical firm will retain its primary listing on the Nasdaq. BHP: The world's largest miner by market value ($125.10 billion) made Australia its primary stock market when it ended its dual-listing structure in 2021. The company was the second largest by market value in London when it left the stock market. Unilever: The Ben & Jerry's maker in February picked Amsterdam as the primary listing for its ice cream business. The business, which generated a turnover of 8.3 billion euros ($9.47 billion) in 2024, will have secondary listings in London and New York. Glencore: The Swiss miner said in February it was considering moving its primary listing from London. The company, with a market value of 34.5 billion pounds, said New York was at the top of the list under consideration. Shein: The online fast fashion retailer is working towards a listing in Hong Kong after its proposed initial public offering (IPO) in London failed to secure the green light from Chinese regulators, three sources with knowledge of the matter told Reuters in May. However, before its attempt to list in London, Shein had pursued a listing in New York, as part of its efforts to gain legitimacy as a global, rather than a Chinese company, and access to a wide pool of large Western investors. Ashtead: The second-largest equipment rental company in the U.S. said in December it plans to shift its listing to New York. With a market value of 18.3 billion pounds, Ashtead has been listed in London since 1986, and transformed into a major U.S. player in the early 2000s. Just Eat Takeaway: The Amsterdam-listed food delivery company delisted from the London Stock Exchange in December, citing efforts to reduce administrative and regulatory costs. The company has a market value of 4.05 billion euros. Flutter Entertainment: The FanDuel-owner in 2024 moved its primary listing to the New York Stock Exchange (NYSE), just a few months after it added a secondary listing in the US. CRH: The building materials solutions provider, which has $61.29 billion in market value, switched its primary listing to the NYSE in 2023, while maintaining a standard listing on the London Stock Exchange. Arm Holdings: The UK-based chip designer chose Nasdaq over London for its 2023 IPO — the largest of that year. The company, now valued at just over $138 billion, was previously listed in London for 18 years till 2016, when it was taken private by SoftBank in a $32 billion acquisition. ($1 = 0.8763 euros) ($1 = 0.7355 pounds) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26 minutes ago
- Yahoo
Stellantis Publishes Agenda for 2025 Extraordinary General Meeting of Shareholders
Stellantis Publishes Agenda for 2025 Extraordinary General Meeting of Shareholders AMSTERDAM, June 5, 2025 – Stellantis N.V. today announced the publication of the agenda and explanatory notes for its 2025 Extraordinary General Meeting of Shareholders (EGM), which is scheduled to take place on July 18, 2025, in Amsterdam. As previously announced, the EGM will resolve the proposed appointment of Mr. Antonio Filosa as an executive director of the Company. Antonio Filosa is a veteran of the Company with a proven track record of hands-on success spanning over 25 years in the automotive industry. He has led Stellantis in both North and South America as well as in Global Quality. During his time as Chief Operating Officer of South America, the FIAT brand gained a market-leading position, along with significant growth in the Peugeot, Citroën, Ram, and Jeep® brands. As a result, Stellantis became a clear industry leader in the region. He led the startup of the Pernambuco plant, one of South America's largest automotive hubs, and launched Jeep® in Brazil, which became the brand's leading market outside of the United States. As CEO of Jeep®, Antonio Filosa expanded the brand's global presence, including in Europe, thanks to very popular products such as the Jeep® Avenger. Since his appointment to the role of Chief Operating Officer, Americas in December 2024, he has initiated the strengthening of U.S. operations, including significantly reducing excessive dealer inventory, reorganizing the leadership team, driving the process of introducing new products and powertrains, and increasing dialogue to improve relationships with dealers, unions and suppliers. The official notice of the EGM, along with explanatory notes and related materials and voting instructions, is now available in the Investors section of the Stellantis corporate website at Shareholders may also request a printed copy of these materials, using the contact information provided below. # # #Stellantis N.V. (NYSE: STLA / Euronext Milan: STLAM / Euronext Paris: STLAP) is a leading global automaker, dedicated to giving its customers the freedom to choose the way they move, embracing the latest technologies and creating value for all its stakeholders. Its unique portfolio of iconic and innovative brands includes Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, FIAT, Jeep®, Lancia, Maserati, Opel, Peugeot, Ram, Vauxhall, Free2move and Leasys. For more information, visit @Stellantis Stellantis Stellantis Stellantis For more information, contact:Fernão SILVEIRA +31 6 43 25 43 41 – ROUSSEL +33 6 87 77 41 82 – Attachment EN-20250605-Stellantis-2025-EGM-AgendaSign in to access your portfolio
Yahoo
27 minutes ago
- Yahoo
Apple EPS Faces 2--3% Hit After Epic Ruling
Apple (NASDAQ:AAPL) is bracing for a 23% EPS headwind after a federal appeals court upheld an injunction requiring link-out payments in the App Store, potentially shifting billions in developer fees over the next two years. Despite this ruling taking effect April 30, May App Store revenue climbed 13% overall (10% in the U.S.), suggesting many developers won't abandon Apple's ecosystem due to the convenience and trust of its billing. Evercore ISI's Amit Daryanani notes the App Store generates about $21 billion in annual sales, with roughly $7 billion of that coming from U.S. developer fees; while a complete fee loss would imply a 6% EPS hit, he expects a more modest impact as developers weigh higher alternative fees against Apple's seamless experience. J.P. Morgan's Samik Chatterjee agrees on a 2%3% EPS drag, citing an AlphaWise survey where 28% of U.S. iPhone users say they'd be extremely likely to link outputting roughly $3.7 billion in revenue at risk and translating to a worst-case 16-cent EPS hit (2%). Morgan Stanley's data also points to a 2% EPS exposure. Gaming accounts for about 65% of U.S. App Store sales, mostly $0.99 one-time purchases; if users switch to payment platforms like Stripe, they could end up paying 3% plus 30 cents per transactionoften more than Apple's 27% commission. Apple insists that over 90% of 2024 billings incurred no commission and emphasizes the App Store's role in helping developers reach a global audience. CEO Tim Cook highlighted that so many developers design great apps, build successful businesses, and reach Apple users through this platform. Investors should watch June App Store metrics and upcoming appellate developments to gauge the long-term financial fallout, since even a small EPS hit matters given Apple's $3 trillion valuation. In other news, Apple has tapped India's Tata Group to handle after-sales repairs for iPhones and MacBooks in India, taking over from Taiwan's Wistron unit, ICT Service Management Solutions. Tata already assembles iPhones at three South India facilitiesone of which produces certain partsand will now carry out repairs at its Karnataka assembly site. This ongoing transition underscores Apple's confidence in Tata as it diversifies manufacturing beyond China, where Tata also assembles devices for domestic and export markets. Apple, Wistron and Tata declined immediate comment. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
